Skip to main content

Table 1 Baseline characteristics of patients according to treatment arms with Plasmodium falciparum and Plasmodium vivax infections

From: Efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated malaria in Papua New Guinea

Characteristics

P. falciparum (N = 274)

P. vivax (N = 70)

AL

DHA-PPQ

P-value

AL

DHA-PPQ

P-value

Males (%)

48

52

0.74

40

60

> 0.99

Mean age (years)

6.5

8.2

0.04

4.5

4.0

0.53

Mean weight (kg)

18.7

19.9

0.33

15.2

14.0

0.53

Mean MUAC (cm)

17.2

17.5

0.48

16.5

16.5

> 0.95

Parasite density/µL

 Median

13,639

26718

< 0.0001

2835

6302

0.07

 Range

1058–26,373

1133–261,992

 

831–157,339

305–86,666

 

 Mean temperature (°C)

37.8

37.5

0.08

37.7

36.9

0.009

 Enlarge spleen (%)

48.7

51.3

0.65

47.4

52.6

0.59

 Mean Hb (g/dL)

9.5

9.5

>0.95

9.7

9.5

0.58

  1. AL artemether–lumefantrine, DHA-PPQ dihydroartemisinin–piperaquine